Share US FDA approves Regeneron's drug for generalized myasthenia gravis

Reuters · REGN · November 18, 2026

US FDA approves Regeneron's drug for generalized myasthenia gravis

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: Reuters ↗